ONCOUROLOGY

Introduction. The incidence of erectile dysfunction (ED) after prostate cancer tretment can reach 50% within 5 years. Since low dose rate brachytherapy (LDRBT) is one of the treatment options for prostate cancer (РСа), it is important to assess the patient's initial sexual profile in order to monitor and manage its progress after the procedure.

The aim of the study was to assess the sexual constitution of patients with localised prostate cancer.

Introduction. Prostate cancer is one of the most common malignancies in men. Along with oncological results, functional results of laparoscopic prostatectomy also play an important role.

Introduction. Fibroepithelial tumor of the urinary tract is a rare disease of mesenchymal origin, consisting of stroma forming the base of the polyp and fibrovascular tissue covered by an epithelial layer. The diagnosis of fibroepithelial polyp is established during cystoscopy or ureteroscopy and based on histological examination, due to the absence of specific symptoms, laboratory tests, and noninvasive criteria that distinguish it from a malignant neoplasm.

Introduction. Paragangliomas, also known as chromaffin tumours, are rare neuroendocrine neoplasms arising from paraganglionic tissue located at various sites in the body. These tumours can be either benign or malignant (up to 10% of cases) and their clinical manifestation is often associated with functional activity that may result in the release of catecholamines into the bloodstream. Paragangliomas are most commonly found in the adrenal glands, but can also localise to the bladder region.

Introduction. The prognosis for patients with bladder cancer has traditionally been determined by the disease stage according to the TNM system. However, this classification does not account for individual tumor biology characteristics such as the degree of differentiation, histological and molecular profile which are necessary for accurately predicting individual disease course and response to therapy. This underscores the need to develop additional prognostic tools. The promising way is the study of systemic inflammation markers, whose role in the progression of various malignant neoplasms has been convincingly demonstrated. However, regarding muscle-invasive bladder cancer (MIBC), the prognostic value of inflammatory indices requires clarification, and a validated model based on them is still lacking, which defines the aim of the present study.

Introduction. Intravesical immunotherapy with bacillus Calmette-Guérin (BCG) is used to treat superficial bladder cancer. The incidence of mycobacterial complications does not exceed 1%, but they can occur with the involvement of the genitourinary and other organs. Aim: to study the clinical and radiological features of tuberculosis associated with intravesical BCG therapy for bladder cancer.